HIGH

ENTECAVIR Entecavir 0.5 mg Tablets Recalled Nationwide Over Impurity (2025)

Ent ecavir 0.5 mg tablets, distributed nationwide in the United States by Zydus Pharmaceuticals USA Inc., are recalled, affecting 912 bottles. The recall is due to an out-of-specification organic impurity detected in a batch, Class II. Healthcare providers and patients should stop using the product immediately and contact Zydus Pharmaceuticals USA for guidance.

Quick Facts at a Glance

Recall Date
September 24, 2025
Hazard Level
HIGH
Brands
ENTECAVIR, ZYDUS PHARMACEUTICALS USA
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Entecavir is an antiviral used to treat chronic hepatitis B in adults and some pediatric patients. It lowers the amount of hepatitis B virus in the body and reduces liver damage.

Why This Is Dangerous

The product failed impurity/degradation specifications. An individual organic impurity detected in the product could pose a health risk if consumed.

Industry Context

This recall is not described as part of a broader industry pattern in the provided information.

Real-World Impact

If contaminated, patients may experience adverse effects from impurity exposure. Consumers should stop use and consult a clinician. There could be disruption to treatment plans.

Practical Guidance

How to identify if yours is affected

  1. Locate the bottle and check the label for NDC 68382-920-06
  2. Look for Lot E409308 on the bottle
  3. Verify Expiration Date 12/31/2026
  4. If the bottle matches, stop using it immediately and contact the distributor

Where to find product info

Identifiers appear on the bottle and outer packaging. The NDC is 68382-920-06. The lot is E409308 and the exp date is 12/31/2026.

What timeline to expect

Refunds or replacements are typically processed within 4-6 weeks after eligibility is confirmed.

If the manufacturer is unresponsive

  • Document all communications with the company
  • Escalate to the appropriate consumer protection agency if the company is non-responsive
  • Consult your healthcare provider for interim treatment guidance

How to prevent similar issues

  • Always verify NDC, lot, and expiration before taking any prescription medication
  • Keep medication packages until you are sure you no longer need them
  • Ask a pharmacist about recall status when receiving new prescriptions

Documentation advice

Keep the recall notice, bottle labels, receipts, and any correspondence. Photograph the product and packaging for your records.

Product Details

Product: Entecavir Tablets, USP, 0.5 mg, 30-count bottle. NDC: 68382-920-06. Manufacturer: Zydus Lifesciences Ltd., Ahmedabad, India. Distributor: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. Lot number: E409308. Expiration: 12/31/2026. Quantity: 912 bottles. Sold nationwide in the USA. Recall date: 2025-09-24.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 912 bottles affected
  • NDC 68382-920-06
  • Lot E409308
  • Exp 12/31/2026

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
5/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot#: E409308
UPC Codes
68382-920
68382-921
68382-920-06
+9 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more